Document Detail


Rituximab-induced subacute interstitial pneumonitis: A case report and review of literature.
MedLine Citation:
PMID:  21119272     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Rituximab is a chimeric anti-CD20 monoclonal antibody used to treat CD20+ non-Hodgkin's lymphoma (NHL). Some pulmonary adverse reactions such as cough, rhinitis, bronchospasm and dyspnea are relatively common. Severe respiratory conditions like cryptogenic organizing pneumonia, interstitial pneumonitis have rarely been reported. We present a case of interstitial pneumonitis in a patient who was treated with R-CHOP for extranodal NHL. He responded to the steroids.
Authors:
Murali Subramanian; R Manjunath; Nalini Kilara; K N Mohan Rao
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cancer research and therapeutics     Volume:  6     ISSN:  1998-4138     ISO Abbreviation:  J Cancer Res Ther     Publication Date:    2010 Jul-Sep
Date Detail:
Created Date:  2010-12-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101249598     Medline TA:  J Cancer Res Ther     Country:  India    
Other Details:
Languages:  eng     Pagination:  344-6     Citation Subset:  IM    
Affiliation:
Department of Medical Oncology, M. S. Ramaiah Medical College, Bangalore - 560 054, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Primary Hodgkin lymphoma of the ileum.
Next Document:  Primary right atrial sarcoma.